Wilkin et al., 2000 - Google Patents
H19 sense and antisense transgenes modify insulin‐like growth factor‐II mRNA levelsWilkin et al., 2000
View PDF- Document ID
- 7253000350867333280
- Author
- Wilkin F
- Paquette J
- Ledru E
- Mamelin C
- Pollak M
- Deal C
- Publication year
- Publication venue
- European journal of biochemistry
External Links
Snippet
The oppositely‐imprinted genes insulin‐like growth factor‐II (IGF2) and H19, a putative tumor suppressor, often show coordinate, reciprocal regulation and are believed to play a role in carcinogenesis. To explore the possible interactions between these genes, we stably …
- 230000000692 anti-sense 0 title abstract description 63
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wilkin et al. | H19 sense and antisense transgenes modify insulin‐like growth factor‐II mRNA levels | |
Wang et al. | PIWI‐interacting RNA HAAPIR regulates cardiomyocyte death after myocardial infarction by promoting NAT10‐mediated ac4C acetylation of Tfec mRNA | |
Berteaux et al. | A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression | |
Avendaño et al. | Disentangling puberty: novel neuroendocrine pathways and mechanisms for the control of mammalian puberty | |
Gabory et al. | H19 acts as a trans regulator of the imprinted gene network controlling growth in mice | |
Velasco et al. | Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues | |
Bian et al. | Epigenetic regulation of miR‐29s affects the lactation activity of dairy cow mammary epithelial cells | |
Gabory et al. | The H19 locus: role of an imprinted non‐coding RNA in growth and development | |
Filippova et al. | Boundaries between chromosomal domains of X inactivation and escape bind CTCF and lack CpG methylation during early development | |
Vallet et al. | Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose | |
Sørensen et al. | MicroRNAs related to polycystic ovary syndrome (PCOS) | |
O'Callaghan et al. | Glucose regulation of the acetyl-CoA carboxylase promoter PI in rat hepatocytes | |
Saur et al. | Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis | |
Kikuchi et al. | Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1α/β and DNA methylation | |
Sharma et al. | MicroRNAs 206 and 21 cooperate to promote RAS–extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1 | |
Hitachi et al. | Myogenin promoter‐associated lnc RNA Myoparr is essential for myogenic differentiation | |
Fitzpatrick et al. | Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1 | |
Hiramuki et al. | Mest but not MiR-335 affects skeletal muscle growth and regeneration | |
Huang et al. | MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis | |
Kim et al. | Poly (C) binding protein family is a transcription factor in μ-opioid receptor gene expression | |
Bullock et al. | Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT | |
Engelbergs et al. | Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea | |
Mirzamohammadi et al. | Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models | |
Nestheide et al. | Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma | |
Lu et al. | Regulation of hepatic microRNA expression by hepatocyte nuclear factor 4 alpha |